By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein biomarker firm Astute Medical today announced the completion of a $13 million financing.

The financing is an extension of a Series B round completed in May that had raised $26.5 million. The San Diego firm also raised $6.2 million in a Series A round in 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.